Table 1. Characteristics of the study cohort including symptomatology at baseline.
| 23–34 weeks ( n = 36) | 34–37 weeks ( n = 29) | p -Value | |
|---|---|---|---|
| Maternal age, median (IQR) (y) | 31.5 (29–34) | 32 (30–35) | 0.65 |
| BMI, median (IQR) (kg/m 2 ) | 32 (27.2–36.6) | 31 (28–36.3) | 1 |
| Race or ethnic group, n (%) | |||
| Non-Hispanic White | 7 (19.4) | 8 (27.6) | 0.39 |
| Non-Hispanic Black | 6 (16.7) | 8 (27.6) | |
| Hispanic | 17 (47.2) | 7 (24.1) | |
| Asian | 4 (11.1) | 3 (10.3) | |
| Other/unknown | 2 (5.6) | 3 (10.3) | |
| Nulliparous, n (%) | 12 (33.3) | 11 (37.9) | 0.8 |
| GA at diagnosis, median (IQR) (wk) | 30.1 (27–33) | 35.3 (34.7–36.1) | <0.001 |
| Presence of comorbidity a , n (%) | 9 (25) | 2 (6.9) | 0.09 |
| SARS-CoV-2 related symptoms, n (%) | |||
| Fever/chills | 28 (77.8) | 15 (51.7) | 0.04 |
| Cough | 30 (83.3) | 15 (51.7) | 0.008 |
| Dyspnea | 18 (50) | 9 (31) | 0.138 |
| Chest pain | 2 (5.6) | 2 (6.9) | 1 |
| Myalgias | 14 (38.9) | 6 (20.7) | 0.18 |
| Nausea/vomiting | 6 (16.7) | 2 (6.9) | 0.28 |
| Diarrhea | 2 (5.6) | 0 (0) | 0.5 |
| Headache | 4 (11.1) | 2 (6.9) | 0.68 |
| Symptoms not directly related to SARS-CoV-2 infection, n (%) | 3 (8.3) | 11 (37.9) | 0.006 |
| Temperature ≥ 100.4°F on evaluation, n (%) | 20 (61.1) | 21 (72.4) | 0.43 |
Abbreviations: BMI, body mass index; GA, gestational age; IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
a
Comorbid conditions included asthma, chronic hypertension, type 2 diabetes mellitus, HIV, and autoimmune disorders.